Neurosense Therapeutics Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$0.88

+0.04 (+5.27%)

As of May 16, 2:24 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +3,919.9% upside

Low Target $27.84

Average Target $35.23

High Target $57.14

Current Price $0.88

Current
$0.88

Target
$35.23

$27.84 $35.23 avg $57.14

Scenario Analysis

Bear Case

$27.84

3,076.6%

Low target

Base Case

$35.23

+3,919.9%

Avg target

Bull Case

$57.14

+6,419.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$2.60

-66.3% from high

52-Week Low

$0.63

+39.1% from low

Target vs 52W High

$35.23

+1,255.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%